FDA accepts Pfizer rare disease drug for review
February 15, 2012Sales and Marketing EMA, FDA, FoldRx, Pfizer, tafamidis meglumine
The FDA has accepted for review Pfizer’s new drug to treat a rare neurodegenerative disease. Pfizer is seeking a licence …
Diabetes – the battle for control
February 15, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes
This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …
Strategic North appoints Paula Lashley as consultant
February 15, 2012Business Services, Medical Communications, Sales and Marketing
Healthcare strategic marketing consultancy Strategic North, who recently reached the final of the Manchester Evening News Business of the Year …
New categories for IPA Best of Health Awards
February 15, 2012Medical Communications Best of Health, IPA
This year’s IPA Best of Health Awards are now open for entries from healthcare advertising agencies worldwide. The annual awards …
Pharma critical of Obama budget
February 15, 2012Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform
President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Watchdog frowns on Botox tweet
February 15, 2012Medical Communications Allergan, Chugai, PMCPA, Twitter
Allergan have been found in breach of the UK Code of Practice after an employee used Twitter to communicate about …
Market access: Communicating the story effectively
February 15, 2012Medical Communications
By Andy Buckland – Principal Medical Writer at Abacus International Successful market access relies on a multitude of activities throughout …
Biogen to pay $563 million for Stromedix
February 15, 2012Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix
Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …
Ablynx appoints Dr Andreas Menrad as its new chief scientific officer
February 15, 2012Business Services, Research and Development, Sales and Marketing Abllynx, Menrad, nanobody
Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …
New PV Legislation Implementation Plan by the European Medicines Agency
February 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation
The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …
Virgo bolsters specialist value and access service
February 14, 2012Medical Communications Jo Jones, NHS, Virgo, Virgo Health Communications
Virgo Health Communications has expanded its UK value and access expertise with the appointment of Tristan Mulholland.Tristan joins as Account …
Merck’s eye drug Zioptan gains FDA approval
February 14, 2012Sales and Marketing Merck, Pfizer, Xalatan, Zioptan
The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …
Premier Research appoints Sean Russell vice president, Marketing
February 14, 2012Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell
Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …
NICE cannot recommend breast cancer drugs
February 14, 2012Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb
NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …
Robust sales for Shire
February 13, 2012Sales and Marketing Replagal, Shire, Vpriv, Vyvanse
A rise in the use of attention deficit and hyperactivity disorder drugs has helped push Shire’s turnover past $4 billion …
Lonza forges joint venture with South Africa for HIV drugs
February 13, 2012Manufacturing and Production HIV, Lonza, South Africa
Swiss contract manufacturer Lonza has signed a joint venture agreement with the government of South Africa that could significantly reduce …
Abbott plans €85m investment in Irish facility
February 13, 2012Manufacturing and Production Abbott. IDA, Ireland, Xinlay
Abbott Laboratories has said it will invest around €85 million in its manufacturing facility in Sligo, Ireland, more than doubling …
Excipient certification scheme launches
February 13, 2012Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing
A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …
Pharma manufacturing news in brief
February 13, 2012Manufacturing and Production Bosch, Lilly/Bend Research, Neuland, OctoPlus Ferring and CHEMO Particle Sciences
Neuland posts revenue gains, Bosch buys Eisi machinery, plus deals for Lilly/Bend Research, OctoPlus/Ferring and CHEMO/Particle Sciences.
Carlyle Ware joins the Fishawack Group
February 13, 2012Business Services, Medical Communications, Sales and Marketing Fishawack Group, PR, fishawack
Med comms specialist the Fishawack Group has appointed Carlyle Ware as its group commercial director. Ware has over 13 years’ …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
